Viewing StudyNCT00080327

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00080327
Status: COMPLETED
Last Update Posted: 2013-11-11
First Post: 2004-03-26
Brief Title: Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
Sponsor: Otsuka Pharmaceutical Development Commercialization Inc
Organization: Otsuka Pharmaceutical Development Commercialization Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Schizophrenia
Keywords: